Addition Therapeutics News and Activities

Acquisition, funding and merger involving Addition Therapeutics.

• Addition Therapeutics has just announced a $107 Million fundraising (posted on December 29 2025).

View the org chart displaying its 15 main executives

Most searched biographies at Addition Therapeutics

• Ron Park, Chief Executive Officer and Director
• Jeni Lee, Director
• Kathleen Collins, Director

Create your alert
to follow the executive moves at Addition Therapeutics.

Addition Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Addition Therapeutics

Social media about Addition Therapeutics

• Addition Therapeutics on Wikipedia, Google News & Yahoo Finance
• Addition Therapeutics on LinkedIn, X (Twitter) & YouTube